HomeCompareDOMA vs MRK

DOMA vs MRK: Dividend Comparison 2026

DOMA yields 31.85% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DOMA wins by $90.4K in total portfolio value
10 years
DOMA
DOMA
● Live price
31.85%
Share price
$6.28
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$147.2K
Annual income
$20,505.89
Full DOMA calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — DOMA vs MRK

📍 DOMA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDOMAMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DOMA + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DOMA pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DOMA
Annual income on $10K today (after 15% tax)
$2,707.01/yr
After 10yr DRIP, annual income (after tax)
$17,430.01/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, DOMA beats the other by $9,101.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DOMA + MRK for your $10,000?

DOMA: 50%MRK: 50%
100% MRK50/50100% DOMA
Portfolio after 10yr
$102.0K
Annual income
$15,152.02/yr
Blended yield
14.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

DOMA
Analyst Ratings
1
Buy
5
Hold
Consensus: Hold
Price Target
$921.88
+14579.6% upside vs current
Range: $281.25 — $1,562.50
Altman Z
-3.1
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DOMA buys
0
MRK buys
0
No recent congressional trades found for DOMA or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDOMAMRK
Forward yield31.85%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$147.2K$56.8K
Annual income after 10y$20,505.89$9,798.13
Total dividends collected$102.7K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$921.88$128.54

Year-by-year: DOMA vs MRK ($10,000, DRIP)

YearDOMA PortfolioDOMA Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$13,885$3,184.71$11,206$366.19+$2.7KDOMA
2$18,989$4,132.60$12,650$502.35+$6.3KDOMA
3$25,601$5,282.15$14,407$694.19+$11.2KDOMA
4$34,048$6,655.33$16,585$967.82+$17.5KDOMA
5$44,704$8,272.31$19,342$1,363.89+$25.4KDOMA
6$57,984$10,150.67$22,913$1,947.19+$35.1KDOMA
7$74,347$12,304.76$27,662$2,823.89+$46.7KDOMA
8$94,297$14,745.13$34,159$4,173.35+$60.1KDOMA
9$118,376$17,478.19$43,337$6,308.80+$75.0KDOMA
10$147,168$20,505.89$56,776$9,798.13+$90.4KDOMA

DOMA vs MRK: Complete Analysis 2026

DOMAStock

Doma Holdings Inc. originates, underwrites, and provides title, escrow, and settlement services to homeowners, lenders, title agents, and real estate professionals. It operates through two segments, Distribution and Underwriting. The company also engages in title insurance underwriting business, including policies referred through its direct agents and third-party agents' channels; and provides services in the areas of purchase and refinance transactions in the residential real estate market. It operates its third-party title insurance agency business under the North American Title Company brand. The company was incorporated in 2016 and is headquartered in San Francisco, California.

Full DOMA Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this DOMA vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DOMA vs SCHDDOMA vs JEPIDOMA vs ODOMA vs KODOMA vs MAINDOMA vs JNJDOMA vs ABBVDOMA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.